drugset / Trial / NCT05551910

Comparison of Analgesic and Sedative Effects of Esmketamine and Remifentanil Combined With Propofol Respectively in Septic Shock Patients With Invasive Mechanical Ventilation

NCT05551910 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Septic shock patients with invasive mechanical ventilation who were randomly enrolled in ICU were divided into esketamine group (test group) and remifentanil group (control group) according to the ratio of 1:1. The dose of vasopressor, the time of mechanical ventilation, the incidence of intestinal dysfunction and the dose of propofol were compared between the two groups. Through statistical analysis, it was determined whether esketamine combined with propofol could improve the prognosis of septic shock patients with invasive mechanical ventilation and reduce the adverse reactions of analgesic and sedative drugs compared with remifentanil combined with propofol.

Timeline

Start
2023-01-01
Primary completion
2025-01-01
Completion
2025-03-01

Outcome

Met primary endpoint

paper The dosage of norepinephrine of esketamine group was less than that of remifentanil group(P=0.007). PMID 40416798 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified — —
Subject Remifentanil Small molecule — —
Background Propofol Small molecule — —

Indications

No indication recorded.